Track 1: Breast Cancer Biology

Breast cancer starts when cells in the breast begin to grow out of control. These cells usually form a tumor that can often be seen on an x-ray or felt a lump. The tumor is malignant (cancer) if the cells can grow into (invade) surrounding tissues or spread (metastasize) to distant areas of the body. Breast Cancer occurs almost entirely in women, but men can get breast cancer, too. This starts from different parts of the breast. Most breast cancers begin in the duck carry milk to the nipple. Many of the breast cancer forms lumps, but not all do. Most of the lumps are begin and not cancer (malignant). Non-cancerous breast tumors are abnormal growths, but they do not spread outside of the breast and they are not life-threatening. Investigating the difficulties concerning brilliance in Breast Cancer Conferences, Oncology Meetings research and experimentation which incorporates provoke keynote introductions, Oral talks, Poster introductions, and Exhibitions.

Track 2: Cervical Cancer Biology

The Cervix is the lower some portion of the uterus which opens into the vagina. At the point when the strange cells of the cervix become crazy, cervical disease happens. Cervical growth can be effectively recognized in the beginning periods by a test called 'Pap test'. Most sorts of cervical disease are caused by an infection known as Human Papillomavirus or HPV. There are many kinds of HPV. However, every kind does not bring about cervical tumor. A few causes genital warts which do not have any side effects. The primary drivers of cervical growth are smoking, use of oral preventative pills and getting various pregnancies. The side effects of cervical malignancy incorporate unpredictable seeping from the vagina other than the conclusive time traverse of general menstrual cycle, torment in the lower stomach area, torment amid sexual relations and irregular vaginal release. Each sort of cervical malignancy isn't lethal to the ladies. Treatment that incorporates surgeries and chemotherapies has been turned out to be fruitful in treating cervical malignancy in the underlying stages.

Track3: Cancer Genomics

Genes are instructions which tell the body how to make all the proteins it needs to survive and grow. Cancer genomics is the investigation of the totality of DNA arrangement and quality articulation contrasts between tumor cells and typical host cells. It expects to comprehend the hereditary premise of tumor cell multiplication and the advancement of the growth genome under transformation and determination by the body condition, the immune system and therapeutic interventions.

In cancer cells, little changes in the hereditary letters can change what a genomic word or sentence implies. A changed letter can make the cell make a protein that doesn't enable the cell to fill in as it should. These proteins can influence cells to develop rapidly and make harm neighboring cells. By concentrate the growth genome, researchers can find what letter changes are making a cell turn into a disease. The genome of a tumor cell can likewise be utilized to disclose to one kind of disease from another. Now and again, examining the genome in a growth can help recognize a subtype of malignancy inside that write, for example, HER2+ breast tumor. Understanding the tumor genome may likewise enable a specialist to choose the best treatment for every patient.

Track4: Immunological Approaches to Cancer Therapy

Cancer immunotherapy (here and there called immuno-oncology) is the utilization of the safe framework to regard cancer. Immunotherapies can be classified as dynamic, inactive or mixture (dynamic and detached). These methodologies abuse the way that growth cells regularly have particles on their surface that can be distinguished by the invulnerable framework, known as tumor-associated antigens (TAAs); they are frequently proteins or different macromolecules (e.g. starches). Dynamic immunotherapy guides the invulnerable framework to assault tumor cells by focusing on TAAs. Uninvolved immunotherapies improve existing hostile to tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes, and cytokines.
The immune system effectively prevents cancer, though extreme immunodepression expands its rate. Malignancy immunoprevention is a procedure in view of the idea that upgrade of tumor insusceptibility in sound people lessens growth to chance. It can be seen as a sort of chemoprevention. For growth immunoprevention, the malignancy universe can be conveniently separated between tumors caused - specifically or in a roundabout way - by irresistible operators and every other tumor. Immunoprevention of tumors caused by irresistible operators is as of now executed at the populace level for hepatitis B infection (HBV); related hepatocellular carcinoma and for tumors caused by human papillomaviruses (HPV), like cervical carcinoma. Presently the test is to create immunological procedures to keep the mass (>80%) of human tumor load, irrelevant to diseases.

Track5: Breast and Cervical Cancer Screening

Cancer among ladies is a noteworthy general medical issue in the United States. Around 40% of American ladies are determined to have a nondermatological growth amid their lifetime, and breast tumor is second just to lung disease as a reason for malignancy-related mortality among women. The cervical disease is the tenth most regular tumor among ladies and records for right around 2% of female malignancy passing. The American Cancer Society predicts that around 40 200 ladies will have kicked the bucket from breast growth and 4400 will have passed on from the cervical disease in the year 2001.

Mammography and Papanicolaou (Pap) tests are fundamental parts of early discovery and treatment, and death rates are significantly diminished when breast and cervical tumors are identified and treated at a beginning time.

Track6: Male Breast Cancer

Breast cancer in men is a rare disease. Less than 1% of all breast cancers occur in men. Man, and women, girls and boys all have breast tissues. The various hormones in girls' and women's bodies stimulate the breast tissue to grow into full breasts. Boys' and men's bodies normally don't make much of the breast-stimulating hormones. As a result, their breast tissue usually stays flat and small. But sometimes men can develop real breast gland tissue because they take certain medicines or have abnormal hormone levels. Breast and Cervical Malignancy Congress incorporates the exchange on future parts of male and female breast disease. In 2017, about 2,470 men are expected to be diagnosed with the disease. For men, the lifetime risk of being diagnosed with breast cancer is about 1 in 1,000.

Track7: Breast Reconstruction (Oncoplastic Surgery)

Breast-conservation surgery (BCS) is set up as a sheltered alternative for most ladies with early breast disease. As of late, propels in oncoplastic procedures have lessened surgical injury and along these lines are equipped for protecting the breast shape and personal satisfaction. Notwithstanding the most BCS deformities can be made do with the essential conclusion, the stylish result might be unusual. Oncoplastic reproduction may start at the season of BCS (quick), weeks (deferred prompt) or months to years thereafter (postponed). With prompt remaking, the surgical procedure is smooth, since the two strategies can be related to one agent setting. Furthermore, it licenses more extensive extraction of the tumor, with a predominant mean volume of the example and conceivably lessening the rate of edge association. The oncoplastic strategies are identified with volume removal or substitution methods including nearby folds, latissimus dorsi myocutaneous fold, and diminishment mammoplasty/mastopexy. Breast and Cervical Cancer Conferences is an unmistakable stage to unite worldwide recognized scholastics in the field of tumor treatments. Maximum breast reconstructions achieved today are instant reconstructions with implants

Track8: Cervical Cancer and Transgender Man

Transgender Man is the quantifiably higher danger of cervical, ovarian, and uterine growth looked by transgender men who hold genitalia they were conceived with. Because of shame and social rejection, numerous don't consistently get gynecological examinations and corresponding cervical and ovarian screenings. Transgender men are in danger of cervical disease. Transgender people are especially helpless against an absence of sufficient social insurance, especially with respect to sexual and regenerative wellbeing. In the majority of the nation’s cervical growth is the main source of malignancy demise, transgender men are in high danger of building up this malady. Though the Papanicolaou test is the most generally utilized screening technique for cervical growth, there are high quantities of unsuitable outcomes among transgender men contrasted and nontransgender people. Human papillomavirus (HPV) testing might be a more practical screening choice in this populace

Track9: Breastfeeding and Breast Cancer

Breastfeeding is a complex yet essential undertaking for some mothers since it might be painful for the soundness of both baby and mother. Studies demonstrate that even insignificant breastfeeding diminishes a lady's danger of breast cancer by around 30 percent. This has even appeared in ladies with a BRCA1 mutation, which builds the hazard for breast growth. On the off chance that a patient is determined to have breast cancer while nursing, most doctors will suggest that they quit breastfeeding. Numerous treatments utilized amid breast malignancy treatment might be passed to the infant through breast milk, including chemotherapies, hormone treatments and anesthesia managed amid surgery. Stopping breastfeeding will likewise diminish blood flow to the breasts, making them smaller, less demanding to look at and more averse to wind up plainly contaminated.

Track10: Chemotherapy and Cancer

Chemotherapy is a cancer treatment that makes use of tablets to stop the boom of most cancers cells, both by way of killing the cells or through preventing them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the medicine enters the bloodstream and may reach most cancers cells in the body (systemic chemotherapy). When chemotherapy is placed immediately into the cerebrospinal fluid, an organ, or a body hollow space including the abdomen, the drugs, in particular, affect most cancers cells in those areas (nearby chemotherapy).Breast and Cervical Cancer Conference has given superb breast and cervical growth screening procedures and diverse method of medications. The manner the chemotherapy is given depends on the type and degree of the most cancers being handled. Systemic chemotherapy is used in the remedy of breast most cancers.

Track11: Molecular Oncology in Breast Cancer

In the present period, sub-atomic oncology has cleared its way in the exhaustive cancer care and is assuming a critical part, particularly in the disclosure of novel cell, focuses to misuse for novel focused on medications, new biomarkers distinguishing proof for early malignancy location, and to give a superior characterization of tumors for guess and treatment choice. The sub-atomic premise of breast carcinogenesis including hereditary and epigenetic occasions that outcome in the changed articulation of various qualities is yet not completely comprehended and still should be deciphered more, which mirrors the unpredictability of the sub-atomic modifications that portray tumor cells.

The majority of the breast malignancy genome is specifically subdued; around, 3-5% of qualities are dynamic in a specific tumor cell that is administered by the direction of quality articulation, for the most part at the level of translation. Cell bother (change) causes changes in quality articulation that outcome in the declaration of many quality items and the concealment of others. Consequently, sub-atomic heterogeneity is created that describes tumors of various histology and adds to the changeability in result and reaction to treatment. Further, huge changeability additionally exists for tumors of a particular histologic write. Till as of late, in breast disease administration, clinical choices, visualizations, and expectations were constructed exclusively upon histopathologic investigation, or one or little quantities of qualities or their appearances (proteins) in the tumor tissue, yet this approach has been deficient and neglected to create exact conclusions. There has been a rise of the new worldview called "Genomic Paradigm," a move from the seniority "Clinico-Pathological Paradigm"

Track12: Cancer Epigenomics: Beyond Genomics

Cancer epigenetics is the investigation of epigenetic alterations to the genome of tumor cells that don't include an adjustment in the nucleotide succession. Epigenetic adjustments are as critical as hereditary transformations behind the progress of a cell from ordinary to malignant, and their control holds awesome guarantee for disease counteractive action, discovery and treatment. In various kinds of growth, an assortment of epigenetic systems can be irritated, for example, hushing of tumor silencer qualities and initiation of oncogenes by adjusted CpG island methylation designs, histone changes and dysregulation of DNA restricting protein.

DNA methylation changes in disease cells incorporate the loss of methylation at regularly methylated arrangements (hypomethylation) and the pickup of methylated successions at locales normally unmethylated (hypermethylation). Growth epigenomics includes the investigation of epigenetic changes in malignancy and can be confused by inquiries of circumstances and end results.

Track13: HPV and Pregnancy

HPV is probably not going to influence pregnancy or child's wellbeing. On the off chance that you have genital warts, they may become quicker amid pregnancy, conceivably from the additional vaginal release that gives the infection a clammy developing condition, hormonal changes, or changes in your immune system. Much of the time, warts won't represent any issues for the patient or her infant. It's workable for you to pass the infection to your child, yet this doesn't occur all the time. Regardless of whether your youngster contracts HPV, he's probably going to defeat it all alone with no side effects or issues. In the far-fetched occasion that your youngster gets the kind of HPV that causes genital warts, he may create warts on his vocal strings and different territories at some point in outset or adolescence. This condition, called repetitive papillomatosis, is intense, yet luckily it's additionally uncommon.

Track14: Nanotechnology / Nanomedicines in Cancer Treatment

The use of nanotechnology in growth treatment offers some energizing potential outcomes, including the likelihood of obliterating malignancy tumors with negligible harm to sound tissue and organs, and additionally the discovery and disposal of diseased cells before they frame tumors. One treatment being worked on includes focused on chemotherapy that conveys a tumor-executing specialist called tumor rot factor alpha (TNF) to growing tumors. TNF is connected to a gold nanoparticle alongside Thiol-derivatized polyethylene glycol (PEG-THIOL), which conceals the TNF bearing nanoparticle from the invulnerable framework. This permits the nanoparticle to course through the circulatory system without being assaulted.

Track15: Cancer Vaccination

Certain sorts of chemotherapy and radiation treatment can debilitate the invulnerable framework, putting malignancy patients at expanded hazard forever undermining diseases. Along these lines, numerous tumor patients may need to get revaccinated against ailments they got immunizations for as youngsters. Antibodies require a sound insusceptible framework that is ready to perceive and execute illness-causing germs. Furthermore, it takes a sound insusceptible framework no less than 2 weeks from the season of immunization to begin perceiving and eliminating germs. That implies inoculation timing is similarly as essential as getting the immunization itself. When all is said in done, immunizations aren’t prescribed amid chemotherapy or radiation treatment.

Track16: Women’s Health and Contraception

Enhancements in the finding and administration of disease have expanded personal satisfaction for patients with malignancy both amid and after treatment. Numerous malignancy patients are seeing someone where sexual movement is a piece of their lives. Unprotected intercourse can bring about pregnancy notwithstanding when the possibility of fruitfulness is viewed as negligible. Pregnancy might be undesired as a result of the potential teratogenic impacts of disease medications, or dread that the pregnancy will adversely influence the course of the growth. Breast and Cervical Cancer Conference has given superb breast and cervical growth screening procedures and diverse method of medications. Ladies experiencing malignancy treatment and female tumor survivors will probably end a pregnancy, an activity that has mental and passionate results. Accordingly, it is vital to give fitting advising about contraception to these ladies.

Track17: Novel Approaches to Cancer Therapeutics

The typical treatment modalities are related to serious symptoms and high harmfulness which thusly prompt low personal satisfaction. This audit envelops novel systems for more powerful chemotherapeutic conveyance planning to create better anticipation. Right now, tumor treatment is a profoundly unique field and huge advances are being made in the improvement of novel growth treatment procedures. As opposed to customary malignancy therapeutics, novel methodologies, for example, ligand or receptor-based focusing on, intracellular medication focusing on, quality conveyance, tumor undifferentiated organism treatment, attractive medication focusing on and ultrasound-interceded sedate conveyance, have included new modalities for growth treatment. 

Track18: Gynecologic Oncology

Gynecologic Oncology is a field of drug that spotlights on malignancies of the female conceptive framework, including ovarian disease, uterine growth, vaginal tumor, cervical disease, and Vulvar malignancy. In Oncology Meeting 2018, speakers will talk about the key focuses with respect to immunotherapy, Immune checkpoint inhibitors to treat disease, and related investigations of tumor inoculation. As authorities, they have broad preparing in the determination and treatment of these tumors.

Track19: Traditional Medicine for Cancer

The natural solution utilizes plants, or a blend of plant separates, to treat disease and advance well-being. The two most normal composes utilized as a part of the UK are Western and Chinese homegrown pharmaceutical. Homegrown drug intends to reestablish your body's capacity to secure, direct and recuperate itself. It is an entire body approach that takes a gander at your physical, mental and enthusiastic prosperity. It is at times called Phyto-medicine, Phyto-therapy or organic solution. Numerous cutting edge drugs are produced using plants. However, botanists don't separate plant substances in the way the medication business does. In Breast and Cervical, Malignancy gatherings will likewise talk about various approaches to avoid growth and related infections. The two most normal sorts of natural medication utilized as a part of the UK are Western and Chinese homegrown pharmaceutical. Less basic composes incorporate Tibetan or Ayurveda medication (Indian).

Track20: Market Segmentation of Cancer in the Asia Pacific and the Middle East

The market for growth treatment in Asia-Pacific is fragmented in light of the kind of treatment, which incorporates chemotherapy, radiotherapy, surgery, hormone treatment, directed tumor treatment, immunotherapy and mix treatment. Chemotherapy, radiation treatment, and combinational treatment are progressively accessible in the Asia-Pacific locale. Be that as it may, chemotherapy is the biggest portion of APAC disease therapeutics advertises. Oncological Occasion 2018 likewise delivers information’s about the market examination of malignancy medications and medicines, hardware. In view of topography, Asia Pacific market is fragmented into China, India, Japan, 

Breast and Cervical Cancer 2018 invites participants, moderators, and exhibitors from everywhere throughout the world to Abu Dhabi, UAE. We are charmed to welcome all of you to go to and enlist for the '' 3rd World Conference on Breast and Cervical Cancer, 2018'' which will be held on September 27-28, 2018 in Abu Dhabi, UAE. The sorting out advisory group is preparing for an energizing and instructive gathering program including entire addresses, symposia, workshops on an assortment of subjects, notice introductions and different projects for members from everywhere throughout the world. We welcome you to go along with us at the BreCeCan-2018, where you will make certain to have an important involvement with researchers from around the globe. All individuals from the Breast and Cervical Cancer-2018 arranging board anticipate meeting you in Abu Dhabi, UAE.

IMPORTANCE AND SCOPE:

Breast and Cervical Cancer 2018 offers with Breast most cancers expertise and traits, Screening, Detecting and Diagnosing Breast most cancers, Breast most cancers therapy, prevention and medicinal drug, surgical operation choices for Breast most cancers, Personalized remedy, medical trials of Breast most cancers, Male Breast cancer and Breast Cancer Nursing. Breast most cancers is the main kind of cancer from which most of the ladies are struggling international. Cognizance approximately the breast most cancers dangers, signs and symptoms and treatment could be very critical. Advent of latest strategies within the area of drugs in addition to prognosis is going on worldwide. Breast cancer convention 2018 offer a platform for sharing of facts approximately the breast most cancers remedy techniques and newly advanced strategies for the same as nicely as offer platform approximately the latest researches on breast most cancers.

This occasion includes activate keynote presentations, oral talks, poster presentations and exhibitions. In line with world Health Organization (WHO) in 2012, round 521,000 people died due to breast most cancers and this variety is predicted to growth within the near destiny. Like different metastatic cancers, surgical elimination of metastatic breast cancer is deemed useless and regularly effects in elevated threat of loss of life (80% - 90% of the recognized population). Prognosis is generally based at the stage of breast most cancers within the patient; this staging is carried out by using the same old TNM staging technique, wherein T stands for tumor, N stands for node swelling, accompanied through TNM i.e. the metastatic stage of the most cancers. Those manifestations are utilized inside the class of metastatic breast most diseases into 4 levels, levels 1-three involves moderate spread of carcinoma from various areas of the breast. But doesn’t contain metastasis; degree 4 shows a full-blown metastasis which indicates involvement of lymph nodes near or remote from the breasts and spread to different organs consisting of bones, lung and the mind.

Cervical cancer is the second maximum usually conventional cancer and the 1/3 greatest cause of loss of life in girls, with 530,000 new instances discovered each 12 month the global cervical most cancers diagnostics exams marketplace is segmented through take a look at kinds into Pap smear exams, colposcopy, HPV checking out, endocervical curettage (ECC) procedure and others, which incorporates cone biopsy and loop electrosurgical excision procedure (LEEP). The Pap smear exams section is also predicted to develop at a CAGR of extra than 6% throughout the forecast period from 2014 to 2020 North America become the largest marketplace for cervical cancer diagnostic tests in 2013. The global cervical cancer diagnostic checks market has been segmented into 4 principals nearby markets: North America, Europe, Asia Pacific and relaxation of global. The marketplace length estimations and forecasts for the length 2012 to 2020 were furnished for each of those areas at a phase stage, in terms of USD million at the side of the CAGR for the forecast period 2014 to 2020. Factors which have pushed the market in North the USA are growing prevalence of cervical most cancers cases, fast technological improvements, and developing attention approximately malignant consequences of cervical most cancers among people. Further, diverse reimbursement rules associated with the remedy of cervical most cancers could most possibly gas the increase of the market within the next few years. However, Asia Pacific is projected to witness the highest boom fee over the forecast period from 2014 to 2020.

              Figure 1: Percentage of  Death Caused by Cervical Cancer According to Age groups.

                      Figure 1: Percentage of  Death Caused by Breast Cancer According to Age groups.

WHY ABU DHABI?

Abu Dhabi has a reputation for effectively facilitating world-class business occasions, thanks to some degree to the soul of participation which exists between the administration, business and neighborhood groups. The 'world's nearby neighbor', at the junction of Africa, the Middle East, and Asia, Abu Dhabi offers simple access to a significant number of the world's biggest and quickest developing economies. 33% of the worldwide populace is inside four hours flying-time and 66% are inside eight hours. The upper hands of picking Abu Dhabi are various: a main worldwide community for business, trade, industry, and tourism, with a dynamic workforce and an administration which keeps on putting resources into key framework and transportation tasks to guarantee a prosperous monetary future. The Emirate prides itself on its business-accommodating approaches. Continuously an exchanging society, it has brought its 'open entryways' soul into the cutting-edge world, pulling in outside business and speculation through facilitated commerce zones, zero salary expense and VAT, and a great corporate tax assessment arrangement. Home to more than 200 nationalities, Abu Dhabi invites people of all foundations and beliefs. It offers a casual, charming and cosmopolitan way of life, a sheltered and secure condition with negligible wrongdoing, excellent settlement and an assorted scope of recreation exercises.

RELATED CONFRENCES:

Related Conferences:  Breast-Cervical Cancer Conferences | Breast- Cervical Cancer Meetings | Breast Cancer Events | Oncology Congress | Cervical Cancer Events

·         Cancer Genomics Conference: New Era for Cancer Prevention, June 25-26, 2018 Dubai, UAE

·         14th Surgical Pathology & Cancer Diagnosis Conferences, May 17-18, 2018 Rome, Italy

·         9th Leukemia and Hematologic Oncology Conferences, October 05-06,2017 London, UK

·         Cancer Therapy Meetings , 2018, July 11-12, 2018 Sydney, Australia

·         World Cancer Summit 2018, July 02-03, 2018 Bangkok, Thailand

·         28th Cancer Science & Therapy Conferences, August 09-10, 2018 Madrid, Spain

·         26th Cancer Nursing & Nurse Practitioners Conferences, July 16-17, 2018, London, UK

·         2nd Women Cancers & Gynecologic Oncology Conferences, Aug 29-30, 2017 London, UK

·         27th Oncology Research & Cancer Stem Cells Conferences, May 10-12, 2018 Frankfurt, Germany

·         25th Cancer Conference, Oct 19-21, 2017 Rome, Italy

·         Gastric Cancer Conferences 2017, 06 Oct - 07 Oct 2017, Valencia, Spain

·         Immuno Oncology Conferences 2017, 07 Dec -10 Dec 2017, Geneva.

·         2nd Women Cancers & Gynecologic Oncology Conferences, Aug 29-30, 2017 London, UK

·         Biomarkers and Cancer Targets, July 16-17, 2018 Dubai, UAE

·         27th Oncology Research & Cancer Stem Cells Conferences, May 10-12, 2018 Frankfurt, Germany

·         Molecular Markers and Cancer Therapeutics, October 8-9, 2018 Dubai, UAE

·         14th Surgical Pathology & Cancer Diagnosis Conferences, May 17-18, 2018 Rome, Italy

·         28th Cancer Science & Therapy Conferences, August 09-10, 2018 Madrid, Spain

·         26th Cancer Nursing & Nurse Practitioners Conferences, July 16-17, 2018, London, UK

·         22nd Global Annual Oncologists Meeting, May 24-25, 2018 Osaka, Japan

·         Gastric Cancer Conferences 2017, 06 Oct - 07 Oct 2017, Valencia, Spain

·         9th Urological Cancers Meetings, 16 Nov-19 Nov 2017, Barcelona, Spain

·         Advanced Breast Cancer Conferences, 02 Nov - 04 Nov 2017, Lisbon.

·         Obstetrics and Gynecology 2018 March 18 – 23, 2018 Boston

RELATED SOCITIES:

EUROPE:

European Society of Oncology Pharmacy; European Society of Surgical Oncology; Organization of European Cancer Institutes; Union for International Cancer Control; Universal Medical Centre; Society of Nuclear Medicine and Molecular Imaging; European Society of Gynaecological Oncology; French Endocrine Society; German Society of ORL HNS; Association, International Association of Endocrine Surgeons; International Federation of Oto-Rhino-Laryngological Societies; International Thyroid Oncology Group; Society of Nuclear Medicine and Molecular Imaging; European Association of Urology; European Society For Medical Oncology; Rational Therapy for Breast Cancer; European Laryngological Society; European Society of Endocrinology; French Endocrine Society; European Society of Skin Cancer Prevention; Society of Nuclear Medicine and Molecular Imaging; European Oncology Nursing Society; European Organization for Research and Treatment of Cancer; Dutch Endocrine Society; Association of European Cancer Leagues; EAU Section of Oncological Urology; European Academy of Cancer Sciences; European Association for Cancer Research, European Association for Neuro-Oncology; European Organization for Research and Treatment of Cancer; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; European Organisation for Treatment of Trophoblastic Disease; European Breast Cancer Coalition EUROPA DONNA; European Cancer Organization; European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer; European School of Oncology; European Society for Medical Oncology; European Society for Therapeutic Radiation and Oncology; European Society of Breast Cancer Specialists; European Society of Gynaecological Oncology; European Society of Oncology Pharmacy; European Society of Breast Cancer Specialists; European Society of Gynecological Oncology; European Society of Paediatric Oncology; European Society of Skin Cancer Prevention; European Society of Surgical Oncology; Mediterranean Oncology Society; Organization of European Cancer Institutes; European Research Organization on Genital Infection and Neoplasia; European Group for Blood and Marrow Transplantation; European Society of Breast Cancer Specialists; European Network of Cancer Registries; European CanCer Organisation; European Oncology Nursing Society.

USA:

Acoustic Neuroma Association; American Association for Cancer Research; American Bone Marrow Donor Registry; American Brain Tumor Association; American Cancer Society; American Childhood Cancer Organization Society for Immunotherapy of Cancer Radiation Therapy; Oncology Group Prevent Cancer Foundation; Pancreatic Cancer Action Network; Oncology Nursing Society; Oncofertility Consortium; Ocular Melanoma Foundation; National Lung Cancer Partnership; National Familial Pancreas; Tumor Registry National Familial Lung Cancer Registry; National Council on Skin Cancer Prevention; National CML Society National Children's Leukemia Foundation; National Cancer Registrars Association; National Brain Tumor Society; Musculoskeletal Tumor Society; Melanoma Research Foundation Lymphoma Research Foundation; Lung Cancer Foundation of America Haematology/Oncology Pharmacy Association; Foundation for Women's Cancer, Society for Neuro-Oncology, Society for Radiation Oncology Administrators; Society of Surgical Oncology, Society of Gynecologic Oncology; Society of Gynecologic Nurse Oncologists;  Southwest Oncology Group American Association of Endocrine Surgeons; American Association of Clinical Endocrinologists; American Head and Neck Society; American Thyroid Association; Association of Women Surgeons; Australian Society of Otolaryngology Head & Neck Surgery; Canadian  Association of Pathologists; Canadian Society of Otolaringology – Head and Neck Surgery; Latin American Cancer Society.

ASIA PACIFIC AND MIDDLE EAST

The National Asian Breast Cancer Initiative, Asian Clinical Oncology Society; Childhood Cancer International; World Cancer Research Fund International; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Korean Society for Head and Neck Oncology; Korean Society of Thyroid-Head and Neck Surgery; Korean Society of Otorhinolaryngology-Head and Neck Surgery; The Israel Society of Head and Neck Surgery and Oncology ; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society, Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asia-Pacific Society of Thyroid Surgery; Brazilian Society of Head and Neck Surgery; Asia-Pacific Cancer Society ; Asian Health Coalition; Asian Breast Cancer Society; Association of Oncologists of Uzbekistan; Chinese Society of Clinical Oncology (CSCO); Hong Kong Cancer Therapy Society; Indian Society of Medical & Paediatric Oncology (ISMPO); Indonesian Society of Hematology and Medical Oncology (ISHMO); Iranian Cancer Association (ICA); Iranian Society of Clinical Oncology (ISCO); Iranian Society of Medical Oncology and Hematology (ISMOH); Japan Society of Clinical Oncology (JSCO); Japanese Society of Medical Oncology (JSMO); Korean Association for Clinical Oncology (KACO); Malaysian Oncological Society; Medical Oncology Group of Australia (MOGA); Myanmar Oncology Society; New Zealand Society for Oncology (NZSO); Oncology Club, Bangladesh; Pakistan Society of Clinical Oncology (PSCO); Philippine Society of Medical Oncology (PSMO); Singapore Society of Oncology (SSO); Taiwan Oncology Society (TOS); Thai Society of Clinical Oncology (TSCO); Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery; The Japan Endocrine Society; The Japan Thyroid Association; Foundation for Head and Neck Oncology;  Israel Endocrine Society; Asian Breast Cancer Society; Asian Health Coalition; Asian Cancer Foundation ; Asian Pacific Prostate Society; Asia-Pacific Cancer Society; Asia Pacific Neuro Endocrine Tumor Society; Asian Society of Head & Neck Oncology; Asian and Oceania Thyroid Association; Asia-Pacific Society of Thyroid Surgery.

Breast Cancer 2017

Breast Cancer 2017 Report

Gratitude’s to all of our honorable speakers, conference attendees, and sponsors. Breast Cancer 2017 Conference was our best ever!

5^th World Congress on Breast Cancer conference, hosted by the Conference Series was held during June 15-17, 2017 London, UK at Holiday Inn London - Brentford Lock, London, UK with the theme “Pioneering Spirit of Enriching the Lives and Wellness of Women”. Magnanimous response and active participation were received from the Editorial Board Members of OMICS Group Journals as well as from the Scientists, Doctors, Professors, Oncologists, Radiologists, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the field of Breast Cancer, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

• Breast Cancer- Present Perspective
• Breast Cancer Therapy, Prevention and Management
• Surgery Choices for Breast Cancer
• Rehabilitation/Survivorship After Treatment
• Breast Cancer- Clinical Trails
• Screening, Detecting, and Diagnosing Breast Cancer
• Case studies
• Male Breast Cancer
• Breast Cancer Nursing
• Personalized Medicine - A Redefined Treatment

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list included:

Lloyd Jenkins

Budwig Center, Spain

Sarah Spiegel 

Virginia Commonwealth University School of Medicine, USA

Valerijus Ostapenko   

National Cancer Institute, Lithuania

Dr. Margarete Fischer-

Bosch-Institute of Clinical Pharmacology, Germany

Yun Gong      

University of Texas-M D Anderson Cancer Center, USA 

Carole Verhoeven

Pantarhei Oncology BV, The Netherlands

Jill Brook Hervik

Vestfold Hospital Trust, Norway

Hong (Amy) Zhang   

University of Texas-MD Anderson Cancer Center, USA

Bashar Zeidan

Royal Hampshire County Hospital, UK

Hongying He 

University of Texas Health Science Center at Houston, USA

Yun Gong

University of Texas-MD Anderson Cancer Center, USA

Steven M. Hill

Tulane University School of Medicine, USA

Zhygulin Andrii

LISOD Israeli Cancer Care Hospital, Ukraine

Uhi Toh

Kurume University School of Medicine, Japan

Manjeet Rao

University of Texas Health Science Center, USA

With the grand success of Breast Cancer-2017, ME Conferences is proud to announce the "3^rd World Conference on Breast and Cervical Cancer” to be held during September 24-25, 2018, Abu Dhabi, UAE

For more information please visit: https://breast-cervical.cancersummit.org